Amalgamated Bank Has $618,000 Stock Position in The Chemours Company (NYSE:CC)

Amalgamated Bank trimmed its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 37.2% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 45,691 shares of the specialty chemicals company's stock after selling 27,023 shares during the quarter. Amalgamated Bank's holdings in Chemours were worth $618,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in Chemours in the fourth quarter worth about $30,702,000. Bank of Montreal Can grew its stake in Chemours by 1,496.4% in the fourth quarter. Bank of Montreal Can now owns 953,240 shares of the specialty chemicals company's stock worth $16,110,000 after purchasing an additional 893,530 shares in the last quarter. Ameriprise Financial Inc. grew its stake in Chemours by 23.8% in the fourth quarter. Ameriprise Financial Inc. now owns 4,373,172 shares of the specialty chemicals company's stock worth $73,907,000 after purchasing an additional 839,849 shares in the last quarter. Millennium Management LLC grew its stake in Chemours by 44.6% in the fourth quarter. Millennium Management LLC now owns 2,507,262 shares of the specialty chemicals company's stock worth $42,373,000 after purchasing an additional 773,537 shares in the last quarter. Finally, Invesco Ltd. grew its stake in Chemours by 141.5% in the fourth quarter. Invesco Ltd. now owns 1,020,001 shares of the specialty chemicals company's stock worth $17,238,000 after purchasing an additional 597,638 shares in the last quarter. 76.26% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Chemours

In other Chemours news, insider Damian Gumpel acquired 13,400 shares of the company's stock in a transaction dated Monday, June 2nd. The shares were acquired at an average cost of $9.22 per share, for a total transaction of $123,548.00. Following the completion of the purchase, the insider owned 123,879 shares of the company's stock, valued at approximately $1,142,164.38. This trade represents a 12.13% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Shane Hostetter acquired 4,450 shares of the company's stock in a transaction dated Monday, May 19th. The stock was acquired at an average price of $11.28 per share, for a total transaction of $50,196.00. Following the completion of the purchase, the chief financial officer directly owned 59,694 shares of the company's stock, valued at $673,348.32. This trade represents a 8.06% increase in their position. The disclosure for this purchase can be found here. Insiders bought 25,672 shares of company stock worth $251,573 over the last quarter. 0.47% of the stock is currently owned by corporate insiders.

Chemours Stock Down 1.7%

Shares of NYSE CC traded down $0.24 during mid-day trading on Friday, reaching $13.81. The company had a trading volume of 3,892,089 shares, compared to its average volume of 2,543,553. The Chemours Company has a twelve month low of $9.13 and a twelve month high of $25.54. The company has a debt-to-equity ratio of 7.01, a quick ratio of 0.83 and a current ratio of 1.75. The stock has a market capitalization of $2.07 billion, a PE ratio of 69.05 and a beta of 1.65. The stock's 50 day moving average is $11.38 and its 200-day moving average is $13.94.

Chemours (NYSE:CC - Get Free Report) last posted its earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a net margin of 0.54% and a return on equity of 23.82%. The company had revenue of $1.37 billion for the quarter, compared to the consensus estimate of $1.36 billion. During the same quarter last year, the business earned $0.32 earnings per share. Chemours's quarterly revenue was up .4% on a year-over-year basis. As a group, equities analysts anticipate that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, June 16th. Stockholders of record on Monday, May 19th were paid a $0.0875 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a dividend yield of 3.17%. Chemours's payout ratio is presently 175.00%.

Analyst Upgrades and Downgrades

CC has been the subject of a number of research reports. Barclays decreased their price target on Chemours from $16.00 to $13.00 and set an "equal weight" rating for the company in a research note on Wednesday, May 28th. The Goldman Sachs Group decreased their target price on Chemours from $21.00 to $14.00 and set a "neutral" rating for the company in a research note on Wednesday, May 14th. Royal Bank Of Canada boosted their price objective on Chemours from $14.00 to $15.00 and gave the stock an "outperform" rating in a research report on Thursday, July 3rd. Morgan Stanley dropped their target price on Chemours from $22.00 to $15.00 and set an "equal weight" rating on the stock in a report on Monday, May 12th. Finally, UBS Group dropped their target price on Chemours from $18.00 to $17.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $17.33.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.